{
  "main_header": {
    "sid": 1291629,
    "name": "NewAmsterdam Pharma Co. NV",
    "stock_name": "NewAmsterdam Pharma Co. NV",
    "full_name": "NewAmsterdam Pharma Co. NV",
    "name_url": "stocks-analysis/newamsterdam-pharma-co-nv",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "35.85",
    "chg": -2.48,
    "chgp": "-6.47%",
    "dir": -1,
    "prev_price": "38.33",
    "mcapval": "2,825.85",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "NL00150012L7",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "997.44 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/newamsterdam-pharma-co-nv-1291629-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is NewAmsterdam Pharma Co. NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-newamsterdam-pharma-co-nv-technically-bullish-or-bearish-3673755",
        "imagepath": "",
        "date": "2025-11-05 11:24:19",
        "description": "As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the RSI is bearish on both weekly and monthly time frames. The Bollinger Bands show a mildly bullish stance in both weekly and monthly periods. Daily moving averages indicate a bullish trend. Dow Theory and OBV show no trend on both weekly and monthly time frames. \n\nThe company has outperformed the S&P 500 significantly, with a year-to-date return of 42.14% compared to the S&P 500's 16.30%, and a one-year return of 104.99% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, driven by the bullish MACD and KST, despite the bearish RSI...."
      },
      {
        "title": "Is NewAmsterdam Pharma Co. NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-newamsterdam-pharma-co-nv-technically-bullish-or-bearish-3670933",
        "imagepath": "",
        "date": "2025-11-04 11:36:14",
        "description": "As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. However, the weekly and monthly RSI readings are bearish, suggesting some weakness in price strength. The Bollinger Bands are bullish on both weekly and monthly time frames, supporting the upward trend. Daily moving averages are bullish, reinforcing the positive short-term outlook. The KST shows a bullish weekly stance but is mildly bearish monthly, while the Dow Theory indicates a mildly bearish weekly view and a mildly bullish monthly perspective. The OBV is mildly bearish weekly but bullish monthly, indicating mixed volume trends. Overall, the indicators suggest a mildly bullish stance, although there are signs of weakness in the weekly RSI and Dow Theory. Multi-period return data is not..."
      },
      {
        "title": "Is NewAmsterdam Pharma Co. NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-newamsterdam-pharma-co-nv-technically-bullish-or-bearish-3666541",
        "imagepath": "",
        "date": "2025-11-03 11:36:02",
        "description": "As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also support a bullish outlook. However, the weekly and monthly RSI readings are bearish, and the KST shows a mildly bearish trend on a monthly basis. Dow Theory presents a mixed view with a mildly bearish weekly stance and a mildly bullish monthly perspective. Overall, the stock has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 122.97% compared to the S&P 500's 19.89%...."
      },
      {
        "title": "Is NewAmsterdam Pharma Co. NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-newamsterdam-pharma-co-nv-technically-bullish-or-bearish-3664655",
        "imagepath": "",
        "date": "2025-11-02 11:19:56",
        "description": "As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also support this view. However, the weekly and monthly RSI readings are bearish, and the KST shows a mildly bearish trend on the monthly timeframe. Dow Theory presents a mixed picture with a mildly bearish weekly outlook and a mildly bullish monthly perspective. The OBV is mildly bearish weekly but bullish monthly.\n\nIn terms of performance, the stock has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 122.97% compared to the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, driven by strong momentum indicators despite some bearish signals in the RSI and KST...."
      },
      {
        "title": "NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/newamsterdam-pharma-hits-day-high-with-805-surge-strong-intraday-performance-3662163",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/NewAmsterdamPha_priceRelatedfactors_3662163.png",
        "date": "2025-10-31 17:07:14",
        "description": "NewAmsterdam Pharma Co. NV has seen notable stock performance, gaining 8.05% on October 30, 2025, and achieving a 36.15% increase over the past month. The company reported significant growth in net sales and maintains 100% institutional holdings, despite facing challenges with negative EBITDA and pre-tax losses."
      },
      {
        "title": "NewAmsterdam Pharma Co. NV Hits New 52-Week High of USD 41.39",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/newamsterdam-pharma-co-nv-hits-new-52-week-high-of-usd-4139-3626697",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/NewAmsterdamPha_priceRelatedfactors_3626697.png",
        "date": "2025-10-16 18:33:54",
        "description": "NewAmsterdam Pharma Co. NV has achieved a new 52-week high, reflecting a remarkable performance with a significant increase over the past year. The company, with a market capitalization of USD 2,826 million, faces challenges such as negative return on equity and a notable debt-to-equity ratio, yet continues to attract attention."
      },
      {
        "title": "NewAmsterdam Pharma Hits New 52-Week High of $39.76, Up 88.77%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/newamsterdam-pharma-hits-new-52-week-high-of-3976-up-8877-3620171",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/NewAmsterdamPha_priceRelatedfactors_3620171.png",
        "date": "2025-10-14 19:01:35",
        "description": "NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 39.76 on October 13, 2025, reflecting an 88.77% increase over the past year. The company, with a market cap of USD 2,826 million, remains unprofitable, highlighting the volatility and potential in the small-cap pharmaceuticals sector."
      },
      {
        "title": "NewAmsterdam Pharma Hits New 52-Week High of $34.62",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/newamsterdam-pharma-hits-new-52-week-high-of-3462-3601719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/NewAmsterdamPha_priceRelatedfactors_3601719.png",
        "date": "2025-10-07 22:06:40",
        "description": "NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 34.62 on October 6, 2025, reflecting its notable performance in the Pharmaceuticals & Biotechnology sector. The company, with a market capitalization of USD 2,826 million, has experienced significant stock fluctuations over the past year."
      },
      {
        "title": "NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/newamsterdam-pharma-co-hits-new-52-week-high-of-usd-3181-3595697",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/NewAmsterdamPha_priceRelatedfactors_3595697.png",
        "date": "2025-10-06 17:45:59",
        "description": "NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 31.81 on October 3, 2025, reflecting strong performance in the pharmaceuticals sector with a 55.84% increase over the past year. The company, with a market cap of USD 2,826 million, remains unprofitable and does not offer dividends."
      }
    ],
    "total": 18,
    "sid": "1291629",
    "stock_news_url": "https://www.marketsmojo.com/news/newamsterdam-pharma-co-nv-1291629"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is NewAmsterdam Pharma Co. NV technically bullish or bearish?

2025-11-05 11:24:19

As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the RSI is bearish on both weekly and monthly time frames. The Bollinger Bands show a mildly bullish stance in both weekly and monthly periods. Daily moving averages indicate a bullish trend. Dow Theory and OBV show no trend on both weekly and monthly time frames. The company has outperformed the S&P 500 significantly, with a year-to-date return of 42.14% compared to the S&P 500's 16.30%, and a one-year return of 104.99% versus 19.89% for the index. Overall, the current technical stance is mildly bullish, driven by the bullish MACD and KST, despite the bearish RSI....

Read More

Is NewAmsterdam Pharma Co. NV technically bullish or bearish?

2025-11-04 11:36:14

As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. However, the weekly and monthly RSI readings are bearish, suggesting some weakness in price strength. The Bollinger Bands are bullish on both weekly and monthly time frames, supporting the upward trend. Daily moving averages are bullish, reinforcing the positive short-term outlook. The KST shows a bullish weekly stance but is mildly bearish monthly, while the Dow Theory indicates a mildly bearish weekly view and a mildly bullish monthly perspective. The OBV is mildly bearish weekly but bullish monthly, indicating mixed volume trends. Overall, the indicators suggest a mildly bullish stance, although there are signs of weakness in the weekly RSI and Dow Theory. Multi-period return data is not...

Read More

Is NewAmsterdam Pharma Co. NV technically bullish or bearish?

2025-11-03 11:36:02

As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also support a bullish outlook. However, the weekly and monthly RSI readings are bearish, and the KST shows a mildly bearish trend on a monthly basis. Dow Theory presents a mixed view with a mildly bearish weekly stance and a mildly bullish monthly perspective. Overall, the stock has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 122.97% compared to the S&P 500's 19.89%....

Read More

Is NewAmsterdam Pharma Co. NV technically bullish or bearish?

2025-11-02 11:19:56

As of 31 October 2025, the technical trend for NewAmsterdam Pharma Co. NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also support this view. However, the weekly and monthly RSI readings are bearish, and the KST shows a mildly bearish trend on the monthly timeframe. Dow Theory presents a mixed picture with a mildly bearish weekly outlook and a mildly bullish monthly perspective. The OBV is mildly bearish weekly but bullish monthly. In terms of performance, the stock has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 122.97% compared to the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, driven by strong momentum indicators despite some bearish signals in the RSI and KST....

Read More

NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance

2025-10-31 17:07:14

NewAmsterdam Pharma Co. NV has seen notable stock performance, gaining 8.05% on October 30, 2025, and achieving a 36.15% increase over the past month. The company reported significant growth in net sales and maintains 100% institutional holdings, despite facing challenges with negative EBITDA and pre-tax losses.

Read More

NewAmsterdam Pharma Co. NV Hits New 52-Week High of USD 41.39

2025-10-16 18:33:54

NewAmsterdam Pharma Co. NV has achieved a new 52-week high, reflecting a remarkable performance with a significant increase over the past year. The company, with a market capitalization of USD 2,826 million, faces challenges such as negative return on equity and a notable debt-to-equity ratio, yet continues to attract attention.

Read More

NewAmsterdam Pharma Hits New 52-Week High of $39.76, Up 88.77%

2025-10-14 19:01:35

NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 39.76 on October 13, 2025, reflecting an 88.77% increase over the past year. The company, with a market cap of USD 2,826 million, remains unprofitable, highlighting the volatility and potential in the small-cap pharmaceuticals sector.

Read More

NewAmsterdam Pharma Hits New 52-Week High of $34.62

2025-10-07 22:06:40

NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 34.62 on October 6, 2025, reflecting its notable performance in the Pharmaceuticals & Biotechnology sector. The company, with a market capitalization of USD 2,826 million, has experienced significant stock fluctuations over the past year.

Read More

NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81

2025-10-06 17:45:59

NewAmsterdam Pharma Co. NV achieved a new 52-week high of USD 31.81 on October 3, 2025, reflecting strong performance in the pharmaceuticals sector with a 55.84% increase over the past year. The company, with a market cap of USD 2,826 million, remains unprofitable and does not offer dividends.

Read More

View All News